Expertise in
19
conditions

Mirian C. Janssen

Nijmegen, GE, NL 
Expertise in
19
conditions
Nijmegen, GE, NL 

Overview

Mirian Janssen practices practicing medicine in Nijmegen, Netherlands.

Ms. Janssen is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Classic Galactosemia, Ballinger-Wallace Syndrome, Galactokinase Deficiency, Galactose Epimerase Deficiency, and Kidney Transplant.

She is actively involved in clinical research, co-authoring 151 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Nijmegen, GE, Netherlands
Other Locations
Maastricht, LI, Netherlands
Spaarne Gasthuis
Haarlem, NH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase IIb Open-label, Multi-centre, Extension Study to Explore the Long-term Safety and Efficacy of KH176 in Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation Who Have Completed the KHENERGYZE Study KH176-202.
A Phase IIb Open-label, Multi-centre, Extension Study to Explore the Long-term Safety and Efficacy of KH176 in Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation Who Have Completed the KHENERGYZE Study KH176-202.
Enrollment Status: Completed
Publish Date: March 06, 2024
Intervention Type: Drug
Study Drug: KH176
Study Phase: Phase 2
A Phase IIb Double-blind, Randomised, Placebo-controlled, Multi-centre, Confirmative Three-way Cross-over Study on Cognitive Function With Two Doses of KH176 in Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation.
A Phase IIb Double-blind, Randomised, Placebo-controlled, Multi-centre, Confirmative Three-way Cross-over Study on Cognitive Function With Two Doses of KH176 in Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation.
Enrollment Status: Completed
Publish Date: August 31, 2022
Intervention Type: Drug
Study Drug: KH176
Study Phase: Phase 2
An Exploratory, Double-blind, Randomized, Placebo-controlled, Single-center, Two-way Cross-over Study With KH176 in Patients With the Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation and Clinical Signs of Mitochondrial Disease
An Exploratory, Double-blind, Randomized, Placebo-controlled, Single-center, Two-way Cross-over Study With KH176 in Patients With the Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation and Clinical Signs of Mitochondrial Disease
Enrollment Status: Completed
Publish Date: February 23, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

151 Total Publications

Gut microbiota alterations in individuals with mitochondrial disease caused by the m.3243A >G mutation.
Gut microbiota alterations in individuals with mitochondrial disease caused by the m.3243A >G mutation.
Journal: Molecular genetics and metabolism
Published: March 04, 2026

Frequently Asked Questions about Mirian C. Janssen

Is Mirian C. Janssen a top-rated expert for Classic Galactosemia?

MediFind is an objective health platform that identifies experts based on real-world data. Mirian C. Janssen is classified as an Distinguished expert for Classic Galactosemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mirian C. Janssen participate in research or clinical trials?

Yes. Mirian C. Janssen has published 151 articles and abstracts on conditions like Classic Galactosemia. You can view a list of Mirian C. Janssen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Janssen's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 10 Advanced Conditions
    View All 38 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile